Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study

  • Read more about Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study

CardioVascular Disease Progression and Prognosis in COVID-19

  • Read more about CardioVascular Disease Progression and Prognosis in COVID-19

Angiotensin 1-7 as a Therapy in the Treatment of COVID-19

  • Read more about Angiotensin 1-7 as a Therapy in the Treatment of COVID-19

Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19

  • Read more about Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19

Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship

  • Read more about Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship

Innovative Support for Patients with SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

  • Read more about Innovative Support for Patients with SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19

  • Read more about Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19

Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19

  • Read more about Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19

Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19

  • Read more about Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19

Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation

  • Read more about Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 237
  • Page 238
  • Page 239
  • Page 240
  • Current page 241
  • Page 242
  • Page 243
  • Page 244
  • Page 245
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA